低侵襲脊椎デバイスのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）

当レポートでは、低侵襲脊椎デバイスのパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 低侵襲脊椎デバイス - パイプライン製品：開発段階別
• 低侵襲脊椎デバイス - パイプライン製品：セグメント別
• 低侵襲脊椎デバイス - パイプライン製品：地域別
• 低侵襲脊椎デバイス - パイプライン製品：規制経路別
• 低侵襲脊椎デバイス - パイプライン製品：推定承認日別
• 低侵襲脊椎デバイス - 進行中の臨床試験

第4章 低侵襲脊椎デバイス - 各社の開発中のパイプライン製品

• 低侵襲脊椎デバイス企業 - パイプライン製品：開発段階別
• 低侵襲脊椎デバイス - パイプライン製品：開発段階別

第5章 低侵襲脊椎デバイスの企業と製品の概要

第6章 低侵襲脊椎デバイス - 近年の発展

• 2024年10月8日：SpineGuard、Cannulated PsiFGuardの510（K）承認を取得
• 2024年9月30日：SpineGuard、仙腸関節固定専用の新しいスマートドリリングデバイス「PsiFGuard」の商業的リリースのFDA承認を取得
• 2024年7月10日：Aurora Spine Corporation、Sixth Annual American Society of Pain & Neuroscience Conferenceに出席
• 2024年7月4日：SurGenTec、Ion Facet Screw Systemの追加の510（K）認可を取得
• 2024年5月30日：キーオピニオンリーダーとのパートナーシップ、成功したトレーニング
• 2024年3月12日：早期発症側弯症治療用の改良型MAGEC Xシステムが英国で使用可能に
• 2024年2月15日：SurGenTec、Ion Facet Screw Systemの追加の510（K）認可を取得
• 2023年12月12日：ZimVie、Vital Spinal Fixation SystemとBrainlab Spine & Trauma Navigationの互換性を発表
• 2023年11月13日：Aurora Spine、投資家への最新情報と2023年度第3四半期の業績報告を目的とした電話会議を予定

第7章 付録

List of Tables

• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Segment
• Minimally Invasive Spinal Devices - Pipeline Products by Territory
• Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimally Invasive Spinal Devices - Ongoing Clinical Trials
• Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• Minimally Invasive Spinal Devices - Pipeline Products by Segment
• Minimally Invasive Spinal Devices - Pipeline Products by Territory
• Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• Minimally Invasive Spinal Devices - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Minimally Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Minimally Invasive Spinal Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Minimally Invasive Spinal Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Minimally Invasive Spinal Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Minimally Invasive Spinal Devices Overview

3 Products under Development

• 3.1 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
• 3.2 Minimally Invasive Spinal Devices - Pipeline Products by Segment
• 3.3 Minimally Invasive Spinal Devices - Pipeline Products by Territory
• 3.4 Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
• 3.5 Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
• 3.6 Minimally Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimally Invasive Spinal Devices - Pipeline Products under Development by Companies

• 4.1 Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• 4.2 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimally Invasive Spinal Devices Companies and Product Overview

6 Minimally Invasive Spinal Devices- Recent Developments

• 6.1 Oct 08, 2024: SpineGuard Receives 510(K) Clearance For Cannulated PsiFGuard
• 6.2 Sep 30, 2024: SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
• 6.3 Jul 10, 2024: Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
• 6.4 Jul 04, 2024: SurGenTec Receives An Additional 510(K) Clearance For Ion Facet Screw System
• 6.5 May 30, 2024: Partnership With Key Opinion Leaders and Successful Trainings
• 6.6 Mar 12, 2024: Modified MAGEC X System for Early Onset Scoliosis Treatment Can Now be used in the UK
• 6.7 Feb 15, 2024: SurGenTec Receives Additional 510(K) Clearance For Ion Facet Screw System
• 6.8 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
• 6.9 Nov 13, 2023: Aurora Spine Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer